A total of 3034 patients from 360 sites were randomised to the two treatment groups: 1520 to lansoprazole 30mg and 1514 to esomeprazole 40mg. No significant differences in demographic parameters ...
Group B patients received lansoprazole 30 mg p.o. twice daily and amoxicillin ... Address correspondence to: Dr. Sharara at P.O. Box 11-0236/16-B, American University of Beirut Medical Center ...
Lansoprazole is a proton pump inhibitor, prescribed for gastric ulcer, duodenal ulcer, gastroesophageal reflux disease (GERD), erosive esophagitis (inflammation of esophagus), and Zollinger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results